Patent ID: 11919921
Assignee: GALECTO BIOTECH AB
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 0:
1. A method for treatment of a disorder relating to the binding of a galectin-3 to a ligand in a mammal, wherein said disorder is selected from the group consisting of inflammation; fibrosis; scarring; keloid formation; aberrant scar formation; surgical adhesions; septic shock; cancer; metastasising cancers; autoimmune diseases; metabolic disorders; heart disease; heart failure; pathological angiogenesis; eye diseases; atherosclerosis; metabolic diseases; asthma and other interstitial lung diseases; liver disorders, wherein a therapeutically effective amount of a compound having the formula I or a pharmaceutically acceptable salt thereof, is administered to a mammal in need of said treatment.